Synovus Financial Corp Horizon Therapeutics Public LTD CO Transaction History

Synovus Financial Corp

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 06, 2023	SELL	$62.39 - $113.8 $113,924 - $207,798	-1,826 Reduced 18.63%	7,973 $907,000
Q3 2022 Oct 27, 2022	BUY	$58.92 - $84.67 $35,116 - $50,463	596 Added 6.48%	9,799 $607,000
Q2 2022 Aug 10, 2022	SELL	$79.4 - $116.36 $158,244 - $231,905	-1,993 Reduced 17.8%	9,203 $730,000
Q1 2022 May 12, 2022	BUY	$86.42 - $109.81 $77,345 - $98,279	895 Added 8.69%	11,196 $1.18 Million
Q4 2021 Feb 14, 2022	BUY	$98.56 - $119.91 $18,627 - $22,662	189 Added 1.87%	10,301 $1.11 Million
Q3 2021 Nov 08, 2021	SELL	$91.91 - $110.37 $396,683 - $476,356	-4,316 Reduced 29.91%	10,112 $1.11 Million
Q2 2021 Aug 11, 2021	SELL	$86.24 - $95.92 $81,065 - $90,164	-940 Reduced 6.12%	14,428 $1.34 Million
Q1 2021 May 11, 2021	SELL	$71.83 - $95.48 $25,355 - $33,704	-353 Reduced 2.25%	15,368 $1.41 Million
Q4 2020 Feb 11, 2021	BUY	$67.0 - $84.39 $29,882 - $37,637	446 Added 2.92%	15,721 $1.14 Million
Q3 2020 Nov 09, 2020	BUY	$55.23 - $79.93 $16,348 - $23,659	296 Added 1.98%	15,275 $1.18 Million
Q2 2020 Aug 10, 2020	SELL	$30.2 - $56.98 $63,299 - $119,430	-2,096 Reduced 12.28%	14,979 $833,000
Q1 2020 Apr 24, 2020	BUY	$24.87 - $38.56 $102,265 - $158,558	4,112 Added 31.72%	17,075 $503,000
Q4 2019 Feb 06, 2020	SELL	$25.43 - $36.67 $62,888 - $90,684	-2,473 Reduced 16.02%	12,963 $472,000
Q3 2019 Nov 01, 2019	BUY	$23.0 - $27.97 $350,934 - $426,766	15,258 Added 8571.91%	15,436 $418,000
Q2 2019 Aug 08, 2019	BUY	$22.81 - $28.48 $4,060 - $5,069	178 New	178 $4,000

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of Synovus Financial Corp, based on Form 13F filings with the SEC.

Stay updated on Synovus Financial Corp with notifications on news.